S Zschäbitz1, F Lasitschka2, D Jäger1, C Grüllich3. 1. Department of Medical Oncology, National Center for Tumor Diseases (NCT). 2. Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. 3. Department of Medical Oncology, National Center for Tumor Diseases (NCT) carsten.gruellich@med.uni-heidelberg.de.
Authors: Michal Chovanec; Zuzana Cierna; Viera Miskovska; Katarina Machalekova; Daniela Svetlovska; Katarina Kalavska; Katarina Rejlekova; Stanislav Spanik; Karol Kajo; Pavel Babal; Jozef Mardiak; Michal Mego Journal: Oncotarget Date: 2017-03-28
Authors: Michal Chovanec; Zuzana Cierna; Viera Miskovska; Katarina Machalekova; Katarina Kalavska; Katarina Rejlekova; Daniela Svetlovska; Dusan Macak; Stanislav Spanik; Karol Kajo; Pavel Babal; Ugo De Giorgi; Michal Mego; Jozef Mardiak Journal: Br J Cancer Date: 2018-02-27 Impact factor: 7.640
Authors: Didier Frappaz; Girish Dhall; Matthew J Murray; Stuart Goldman; Cecile Faure Conter; Jeffrey Allen; Rolf Dieter Kortmann; Daphne Haas-Kogen; Giovanni Morana; Jonathan Finlay; James C Nicholson; Ute Bartels; Mark Souweidane; Stefan Schönberger; Alexandre Vasiljevic; Patricia Robertson; Assunta Albanese; Claire Alapetite; Thomas Czech; Chin C Lau; Patrick Wen; David Schiff; Dennis Shaw; Gabriele Calaminus; Eric Bouffet Journal: Neuro Oncol Date: 2022-04-01 Impact factor: 13.029